Despite advances in treatment, age-related cardiac dysfunction still remains a leading cause of cardiovascular death. Recent data have suggested that increases in cardiomyocyte apoptosis may be involved in the pathological remodeling of heart. Here, we examine the effects of aging on cardiomyocyte apoptosis in 6-, 30-, and 36-month-old Fischer344xBrown Norway F1 hybrid rats (F344XBN). Compared with 6-month hearts, aged hearts exhibited increased TdT-mediated dUTP nick end labeling -positive nuclei, caspase-3 activation, caspase-dependent cleavage of a -fodrin and diminished phosphorylation of protein kinase B/Akt (Thr 308). These age-dependent increases in cardiomyocyte apoptosis were associated with alterations in the composition of the cardiac dystrophin glycoprotein complex and elevated cytoplasmic IgG and albumin immunoreactivity. Immunohistochemical analysis confi rmed these data and demonstrated qualitative differences in localization of dystrophin -glycoprotein complex (DGC) molecules with aging. Taken together, these data suggest that aging-related increases in cardiac apoptotic activity model may be due, at least in part, to age-associated changes in DGC structure.
A DVANCING age is associated with increased risk of cardiovascular disease and a progressive decrease in cardiac function ( 1 ) . Recent investigation using the Fischer 344xBrown Norway F1 hybrid (F344XBN) rat model has demonstrated similar changes as aging in these animals is associated with an increased incidence of cardiac arrhythmias as well as impairment of systolic and diastolic function ( 2 , 3 ) . In addition, other data have shown that the aged F344XBN heart exhibits increased expression of oxidativenitrosative stress markers ( 4 ) . Reactive oxygen species (ROS) such as superoxide anions ( 2 O ) and hydroxy radicals ( • OH) have been implicated in cardiac dysfunction, remodeling, and in cardiomyocyte apoptosis ( 5 ) . Whether aging in the F344XBN heart is associated with changes in cardiac apoptosis is not well understood.
The dystrophin -glycoprotein complex (DGC) is located within the cell membrane and provides a strong mechanical link between the cell cytoskeleton and the extracellular matrix ( 6 ) . In cardiac muscle, disruption of DGC may be involved in mediating contractile dysfunction, the development of arrhythmias, and the progression of cardiac hypertrophy ( 7 -14 ) . How the cardiac DGC may be affected by aging and whether changes in the DGC may be related to increases in cardiac apoptosis have not been elucidated. Known components of the DGC include dystrophin, dystroglycans, sarcoglycans, integrins, caveolin-3, and others. The regulation of these proteins differs depending on muscle type ( 15 ) and is altered, at least in skeletal muscle, with aging ( 16 ) . Here, we hypothesized that aged F344XBN hearts exhibited age-related changes in cardiac function and morphology ( 3 , 4 ) and would also exhibit increases in cardiac apoptosis and that this fi nding would be associated with alterations in the expression and localization of DGC proteins. Although incapable of proving cause and effect, the data of the present study suggest that alterations to the cardiac DGC may be implicated in the pathogenesis of agerelated cardiac dysfunction.
M aterials and M ethods

Animals
Animal care and procedures were conducted in accordance with the Animal Use Review Board of Marshall University using the criteria outlined by the American Association of Laboratory Animal Care (AALAC) as proclaimed in the Animal Welfare Act (PL89-544, PL91-979, and PL94-279). The animals and tissues used in this study have been previously examined ( 3 , 4 ) . Adult (6 months, n = 8), aged (30 months, n = 8), and very aged (36 months, n = 8) male F344XBN rats were obtained from the National Institute on Aging. Rats were housed two per cage in an AALAC -approved vivarium. Housing conditions consisted of a 12 hour:12 hour dark -light cycle with temperature maintained at 22 ± 2°C. Animals were provided food and water ad libitum. Rats were allowed to acclimate to the housing facilities for at least 2 weeks before experimentation began. During this time, the animals were carefully observed and weighed weekly. None of the animals exhibited signs of failure to thrive, such as precipitous weight loss, disinterest in the environment, or unexpected gait alterations.
Materials
Antibodies used were dystrophin (dys-2) from Novacastro (Ontario, Canada); a -dystroglycan (sc-28534), bdystroglycan (sc16165), b -sarcoglycan (Sc-28279), and d -sarcoglycan (Sc-28281) were from Santa Cruz (Santa Cruz, CA); a -sarcoglycan (VP-A105) from Vector Laboratories (Burlingame, CA); rat albumin (ab53435) from Abcam; and rat IgG antibody (T6392) from Molecular Probes (Eugene, OR). Caspase 3 (9662), caspase 9 (9506), a -fodrin (2122), Akt (9272), Thr 308 phosphorylated Akt (9275), anti-rabbit (7074) and anti-mouse (7076) IgG secondary antibodies were purchased from Cell Signaling Technology (Beverly, MA). The In Situ Cell Death Detection Kit, Fluorescein (TdT-mediated dUTP nick end labeling [TUNEL]) was from Roche Diagnostics (Mannheim, Germany). Precast 10% sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE) gels were procured from Cambrex Biosciences (Baltimore, MD), and enhanced chemiluminescence (ECL) Western blotting detection reagent was from Amersham Biosciences (Piscataway, NJ). Restore Western blot stripping buffer was obtained from Pierce (Rockford, IL); 3T3 and L6 cell lysates were from Santa Cruz Biotechnology (Santa Cruz, CA). All other chemicals were purchased from Sigma (St. Louis, MO).
Cardiac Morphology
Animals were anesthetized with an intraperitoneal injection of ketamine (40 mg/kg) and xylazine (10 mg/kg), supplemented as necessary for refl exive response. Hearts were quickly removed, blotted dry, weighed, and immediately frozen in liquid nitrogen before storing at − 80°C until use. Histological imaging and immunohistochemistry were performed on hearts sectioned (8 m m) using an IEC Minotome cryostat and collected on polylysine-coated slides (Sigma). Sections were stained with mallory phosphotungstic acid hematoxylin (PTAH) staining as outlined by the manufacturer (Poly Scientifi c R & D Corp ., Bay Shore, NY) for the evaluation of cardiac morphology. Immunostaining for dystrophin, rat IgG, and albumin was performed as outlined by the antibody manufacturer. Briefl y, sections were incubated for 30 minutes in a blocking solution (5% bovine serum albumin [BSA] and phosphate-buffered saline [PBS] containing 0.5% Tween 20 (PBS-T), pH 7.5) and then incubated with specifi c antisera diluted in PBS-T (anti-dystrophin 1:100, rat-IgG 1:100) for 1 hour at 37°C in a humidifi ed chamber. After washing in PBS-T (3 × 5 minutes), sections were incubated with the appropriate FITC or Texas RED labeled secondary antibody (1:200), if appropriate, for 1 hour at 37°C in a humidifi ed chamber. After mounting, specimens were visualized by epifl uorescence using an Olympus fl uorescence microscope (Melville, NY) fi tted with a ×40 objective or on a Nikon Diaphot microscope (Bio-Rad, Hercules, CA) for confocal analysis. To allow approximate qualitative comparisons, all imaging parameters were kept constant between samples.
TUNEL Staining
DNA fragmentation after staining for dystrophin was determined by TUNEL according to the manufacturer ' s recommendations. TUNEL staining was performed on tissue sections (8 m m) obtained from 6-month ( n = 3), 30-month ( n = 3), and 36-month ( n = 3) hearts, which were fi xed with 4% paraformaldehyde, washed with PBS (pH 7.4), and then permeabilized with 0.1% sodium citrate and 0.1% Triton-X. Additional experiments performed in parallel using DNase I or the omission of labeling reagent were used as positive and negative controls. Three randomly selected regions from each cross section were visualized by epifl uorescence using an Olympus fl uorescence microscope fi tted with a ×20 objective. Images were recorded digitally using a CCD camera (Olympus).
Protein Isolation and Immunoblotting
For the preparation of protein isolates, heart tissues were pulverized in liquid nitrogen using a mortar and pestle and washed three times with ice-cold PBS. Cytoplasmic proteins were extracted under mild conditions by incubating samples on ice in 2 m l/mg of T-PER (Pierce) protein extraction reagent that had been supplemented with (1.50 mM MgCl 2 , 1 mM EDTA, 1 m g/mL aprotinin, 1 m g/mL leupeptin, 1 m g/mL pepstatin, 1 mM phenylmethanesulphonylfl uoride (PMSF) , 1 mM Na 3 VO 4 ) for 5 minutes. After centrifugation (10 minutes at 800 g ), the supernant was removed and the pellets were reextracted twice. Membrane proteins were obtained by resuspending the pellet from the previous cytoplasmic extraction from the pulverized heart tissues (1 mL/g) in a buffer containing 1% deoxycholate, 1% NP-40, 10 mM NaPO 4 , 140 mM NaCl, and 2 mM EDTA supplemented with 100 mM NaF, 1 mM Na 3 VO 4 , 2 mM PMSF, 1 m g/mL aprotinin, 1 m g/mL leupeptin, and 1 m g/mL pepstatin. After collecting the supernatant by centrifugation for 10 minutes at 800 g , protein concentration was determined in triplicate via the Bradford method (Pierce) using BSA as a standard. Samples were analyzed using 10% SDS-PAGE. To allow direct comparisons between age groups, 30 m g of samples from different age groups were loaded into consecutive wells of the same gel and ran. Following electrophoresis, proteins were transferred onto Hybond nitrocellulose membranes (Amersham Biosciences) using standard conditions ( 17 ) . Membranes were stained with Ponceau S, and the amount of protein quantifi ed by densitometric analysis to confi rm successful transfer of proteins and equal loading of lanes as described previously ( 18 -20 ) . Membranes were blocked in tris-buffered saline (TBS) with 0.5% Tween 20 (TBS-T) and 5% milk for 1 hour at room temperature, washed (TBS-T, 3 × 5 minutes), and incubated in primary antibody overnight at 4°C or 1 hour at room temperature as outlined by the antibody manufacturer. Immunoreactive protein bands were visualized by ECL Western blotting detection reagent. Film exposure time was adjusted to keep the integrated optical densities (IODs) within a linear and nonsaturated range, and band intensity was quantifi ed by AGING HEART AND THE DYSTROPHIN COMPLEX 149 densitometry using a fl atbed scanner (Epson Perfection 3200 PHOTO scanner, Epson America Inc., Long Beach, CA) and imaging software (AlphaEaseFC, Alpha Innotech, San Leandro, CA). Immunoblots were stripped with Restore Western blot stripping buffer as outlined previously ( 21 ) .
Statistical Analysis
Results are presented as mean ± SEM . Data were analyzed by using SigmaStat 3.0 (Systat Software Inc., Point Richmond, CA) computer software . One-way analysis of variance ( 22 ) was used for overall comparisons, with the Student-NewmanKeuls post hoc test used to determine statistical signifi cance. The level of signifi cance accepted a priori was p ≤ .05 .
R esults
As reported previously ( 3 , 4 ) , the body weight, heart weight, and body weight to heart weight ratios of these animals were increased in 30-and 36-month compared with 6-month animals ( p < .05). PTAH staining of 6-month hearts demonstrated distinct myocyte striations, whereas very aged hearts showed presence of connective tissue infi ltration and loss of myocytes ( Figure 1 ) .
Aging in the F344XBN Heart is Associated With Increased TUNEL Positive Nuclei, Elevated Caspase-3 Activation, and Diminished Akt Phosphorylation
To investigate the possibility that aging was associated with an increase in cardiac apoptosis, we examined the number of nuclei staining positively for DNA fragmentation by TUNEL staining. Compared with 6-month hearts, the number of TUNEL positive nuclei appeared to be markedly increased in 30-and 36-month hearts ( Figure 2 ) .
A critical step in the execution of the apoptotic program that elicits DNA fragmentation is cleavage of caspase-3 into 19 and 17 kDa fragments ( 23 ) . Caspases are cysteine-dependent aspartate-specifi c proteases functioning as endonucleases integral in the fi nal execution of nuclei and cell death ( 23 , 24 ) . With aging, the amount of full-length (inactive) caspase-3 was 39% higher ( p < .05) in 30-month hearts, whereas it was 10% lower in 36-month hearts as compared with 6-month hearts ( Figure 3 ; p < .05). Caspase-3 cleavage into 17 kDa fragments was markedly higher (139%, p < .05) in the 36-month hearts compared with that observed in 6-month animals ( Figure 3 ) . Similarly, the 19-kDa fragment of caspase-3 was also 32% ( p < .05) and 192% ( p < .05) higher in the 30-and 36-month hearts, respectively ( Figure 3 ) .
To examine the upstream signaling events responsible for caspase-3 activation, we next investigated the regulation of the caspase-9. Caspase-9 is cleaved and activated via mitochondrial cytochrome c release ( 25 ) . Full-length (inactive) caspase-9 content was 31% higher in 36-month hearts ( p < .05) compared with 6-month hearts ( Figure 4 ) . The 40-kDa fragment of caspase-9 was higher (35%) in 36-month hearts ( p < .05), with no signifi cant difference between 6-and 30-month hearts ( Figure 4 ) .
As a means of further verifying the activation of caspase-3, we also examined the effects of aging on the cleavage of a -fodrin. a -Fodrin is a cytoskeletal protein which undergoes caspase-dependent proteolytic processing in many types of cell death ( 26 ) but has not, to our knowledge, been studied in aging cardiac muscle. Compared with 6-month animals, the amount of a -fodrin was 14% lower in 30-month hearts ( Figure 4 ) . The full-length 240-kDa afodrin protein can be cleaved at several sites within its sequence by activated calpains to yield an N-terminal fragment of 150 kDa or by caspases to yield a C-terminal 120 kDa product ( 27 , 28 ) . Compared with hearts obtained from 6-month animals, the amount of the caspase-dependent (120 kDa) form of a -fodrin cleavage was 24% lower ( p < .05) in 30-month and 17% higher ( p < .05) in 36-month hearts ( Figure 4 ) . The calpain-dependent (150-kDa) fragment of a -fodrin cleavage was undetectable.
The Akt/PKB is a serine/threonine protein kinase that functions as a critical regulator of cell survival and proliferation through numerous antiapoptotic actions ( 29 ) . Given our fi ndings of increased TUNEL positive nuclei, we hypothesized that aging would be associated with reduced Akt expression. The content of Akt was 28% and 14% lower ( p < .05) in 30-and 36-month hearts compared with 6-month hearts ( Figure 4 ) . Furthermore, Akt phosphorylation (Thr 308) was reduced by 24% and 26% ( p < .05) in the 30-and 36-month hearts, respectively ( Figure 4 ). Taken together, these data suggest that aging in the F344XBN heart is associated with increased cardiomyocyte apoptosis.
Aging in the F344XBN Heart is Associated With Alterations in the Cardiac DGC and Cardiac Membrane Integrity
Immunoblots of protein isolates obtained from the cytosolic and membrane fraction of 6-, 30-, and 36-month hearts were examined for the relative abundance of dystrophin. Compared with 6-month animals, the amount of cytoplasmic dystrophin protein was 26% and 23% higher ( p < .05) in 30-and 36-month hearts, respectively ( Figure 5A ). Relative to 30-month animals, the amount of dystrophin in the membrane fraction was 44% less ( p < .05) in 36-month animals. To assess the subcellular distribution of dystrophin, tissue sections from hearts of differently aged animals were examined by immunohistochemistry. Antibodies directed against the COOH terminus of dystrophin showed uniform immunoreactivity located predominantly along the cell membrane in the 6-month heart ( Figure 5B ). In comparison, dystrophin immunoreactivity in 30-and 36-month heart fi bers appeared irregular with patches of intense fl uorescence. With aging, the dystrophin immunoreactivity often appeared to be discontinuous and was at times completely absent along the sarcolemma ( Figure 5B ).
Because alterations in the amount of dystrophin may infl uence the composition of the DGC, we next examined whether aging may affect the regulation of dystroglycans and sarcoglycans. Compared with 6-month animals, immunoblot analysis showed that the amount of a -dystroglycan was 44% and 74% higher in cytosol and 16% and 23% higher in membrane fraction of 30-and 36-month hearts, respectively ( p < .05) ( Figure 6A ), indicating that the amount of a -dystroglycan being localized to sarcolemma was diminished with aging. Compared with 6-month hearts, the amount of cytosolic b -dystroglycan was 36% and 37% lower in 30-and 36-month hearts, respectively ( p < .05; Figure 6B ). In contrast, the amount of membrane b -dystroglycan was unchanged and 58% higher ( p < .05 ) in 30-and 36-month hearts compared with that observed in 6-month old animals ( Figure 6B ). Immunoblot analysis using an antibody to a glycosylated epitope showed that the cardiac muscle membrane content of a -sarcoglycan was slightly decreased by 8.5% and 14%, respectively ( p < .05) in 30-and 36-month Figure 4 . Aging alters the regulation of mitochondrial dependent apoptotic pathway signaling proteins. Protein isolates from cytosolic fraction of hearts excised from adult (6-month), aged (30-month), and very aged (36-month) rats were analyzed by immunoblotting for changes in caspase-9, a -fodrin, Akt, and Akt phosphorylation (Thr308). Ponceau S staining of the nitrocellulose membrane along with densitometric analysis of protein present was done to verify equivalent protein loading between the lanes (data not shown). n = 8 for all groups. hearts compared with 6-month animals ( Figure 7 ) . Similarly, membrane b -sarcoglycan content was reduced by 12% and 16% in 30-and 36-month hearts, respectively ( p < .05; Figure 7 ). Likewise, compared with 6-month hearts, the amount of d -sarcoglycan was reduced by 28% and 19% in 30-and 36-month hearts, respectively, ( p < 0.05; Figure 7 ) . Together, these data suggest that aging in the F344XBN heart is associated with changes in the composition of the cardiac DGC.
Because DGC is known to play a pivotal role in stabilizing the muscle cell membrane and changes in cardiomyocyte membrane permeability are associated with cellular apoptosis ( 30 ), we next examined whether alterations in the DGC complex were associated with evidence of increased membrane permeability. To test this possibility, tissue sections obtained from 6-, 30-, and 36-month rat hearts were examined for the presence of IgG (150 kDa), a serum protein, and albumin, a plasma constituent that is normally excluded from entry into the muscle fi ber. No evidence of IgG ( Figure 8A ) and albumin ( Figure 8B ) immunoreactivity was demonstrated in the cytosol of cardiac muscle fi bers obtained from Figure 6 . Aging alters the regulation of dystroglycans in the F344XBN heart. Protein isolates from cytoplasmic and membrane fractions of hearts excised from adult (6-month), aged (30-month), and very aged (36-month) rats were analyzed by immunoblotting for changes in ( A ) a -dystroglycan and ( B ) b -dystroglycan protein expression. Ponceau S staining of the nitrocellulose membrane along with densitometric analysis of protein present was done to verify equivalent protein loading between the lanes (data not shown). Asterisk indicates signifi cant difference from adult (6-month) value ( p < .05). Dagger indicates signifi cant difference from 30-month muscles ( p < .05). n = 8 for all groups.
6-month rats. In contrast, very aged rats exhibited positive staining with anti-rat IgG and anti-rat albumin antibodies in the cytoplasm of cardiac myofi bers obtained from 36-month rats ( Figure 8A and B ) . This fi nding consistent with the notion that aging in the F344XBN heart is associated with increased cardiomyocyte permeability.
D iscussion
In the present investigation, we examined how aging may affect cardiomyocyte apoptosis in the hearts of animals that have previously been shown by echocardiography to exhibit age-related dysfunction and biochemically to exhibit increased oxidative -nitrosative stress ( 3 , 4 ) . Here, we demonstrate that aging in the F344XBN rat heart is associated with changes in cardiac morphology and an increase in the number of TUNEL positive cells ( Figures 1 and 2 ). These data, considered in concert with our previous fi ndings, suggest that aging-associated increases in oxidativenitrosative stress may be related to cardiomyocyte loss.
In order to investigate potential mechanisms of the apoptosis observed in our TUNEL studies, we determined how aging affected the expression and activation of two key effectors of mitochondrial-mediated apoptosis, caspase-3 and -9 ( 31 -33 ) . With advanced aging, we observed increases in the amount of cleaved caspase-3 and its upstream activator, caspase-9 ( Figures 3 and 4 ) . Supporting the possibility that caspase-3 activation occurs with aging, we also observed that the amount of caspase-cleaved a -fodrin content was increased with advanced aging ( Figure 4 ) . Taken together, these data support the notion that the mitochondrial apoptotic cascade may contribute to apoptosis in the aging F344XBN
heart. This is in agreement with the results of other recent investigations that have implicated mitochondrial-mediated apoptosis in the loss of cardiomyocytes with aging ( 34 , 35 ) . In addition to increased proapoptotic caspase activity, we also demonstrate that age-related increases in the cardiac apoptosis in the F344XBN are associated with decreased phosphorylation of Akt ( Figure 4 ). Why Akt phosphorylation may be decreased with aging is currently unclear.
Alterations to the muscle DGC and how these changes may infl uence muscle morphology or function have been well examined in the muscular dystrophies ( 36 , 37 ) . Duchenne and Becker muscular dystrophies are associated with a high incidence of dilated cardiomyopathy ( 7 , 38 ) , and dystrophin mutations are a cause of X-linked dilated cardiomyopathy ( 12 , 39 ) . These observations suggest that structural and functional impairments of DGC may serve to promote cardiac dysfunction ( 40 ) . Thus, we hypothesized that age-related disruptions of cardiac DGC function may be partially responsible for the degenerative role of normative aging on heart function. One of the main fi ndings of the present study is that aging in the F344XBN rat heart is associated with alterations in the expression levels of dystrophin ( Figure 5 ), dystroglycans ( Figure 6 ), and sarcoglycans ( Figure 7 ) . Interestingly, the regulation of these proteins appears to occur in a diametric fashion. For example, although the amount of a -, b -dystroglycan protein levels increases in the membrane fraction with aging, the amount of dystrophin and the a -, b -, and dsarcoglycans decrease. It has been hypothesized that b -dystroglycan acts as a link between proteins in the DGC complex and the extracellular matrix ( 41 ) . Thus, it is tempting to speculate that the age-associated upregulation of the dystroglycans that we show may represent an attempt by the cardiomyocyte to " re-establish " a functional connection between the cell cytoskeleton and the extracellular matrix. Although not examined here, it is interesting to note that previous work has demonstrated that inhibition of a -dystroglycan binding to laminin-2 is associated with diminished Akt phosphorylation and the induction of apoptosis in muscle cell cultures ( 42 ) . Whether the decreased phosphorylation of Akt we observe in the aging F344XBN heart is due to alterations in the interaction between adystroglycan and laminin-2 or some other mechanism will require further investigation.
Although the exact function of DGC is not fully understood, it is known to regulate the structural stability of the muscle cell membrane. Indeed, alterations in dystroglycan or sarcoglycan levels have been shown to cause muscle membrane instability ( 43 , 44 ) , and cardiomyocytes lacking dystrophin are abnormally vulnerable to mechanical stress -induced injury causing loss of sarcolemmal integrity and myofi brillar degeneration that can lead to contractile dysfunction ( 6 , 45 ) . Our fi ndings of increased intracellular cytoplasmic IgG and albumin immunoreactivity in the aged F344XBN hearts ( Figure 8 ) are consistent with this notion. This destabilization of the membrane, in turn, has been linked to increased cellular apoptosis ( 42 , 46 ) , which is in agreement with our fi nding of increased cardiomyocyte apoptosis with aging. Whether changes in the DGC precede elevations in cardiac ROS and apoptosis or if alterations in cardiac ROS and apoptosis occur prior to modifi cation of the DGC is not known and, unfortunately, cannot be determined from the present data. Future studies using cultured cardiomyocytes and siRNAs to alter expression of different DGC proteins may be useful in increasing our understanding of the cause and effect relationship between cardiomyocyte apoptosis and age-related changes in DGC.
In summary, this study demonstrates that aging in the F344XBN rats is characterized by increased cardiomyocyte apoptosis and alterations in the expression and localization of cardiac DGC proteins. Although not capable of proving cause and effect, these data when considered in conjunction with our previous reports are consistent with the possibility that age-associated increases in cardiac dysfunction, oxidative -nitrosative stress, and apoptotic activity in the F344XBN aging model may be due, at least in part, to age-related changes in DGC structure and function ( Figure 9 ) ( 3 , 4 ) . Further experiments using other time points within the aging spectrum and other types of analysis will no doubt be useful in determining if this venue is worth exploring. Figure 9 . Proposed model for how changes in the dystrophin -glycoprotein complex (DGC) may be related to age-related cardiac dysfunction. Data from the literature support the existence of increased oxidative stress and contractile dysfunction in aged cardiac muscle. Changes in the cardiac DGC could contribute to each of these processes either directly or by causing changes in cell permeability or by increasing myocyte apoptosis. Dashed arrows indicate cellular mechanisms that have been postulated to participate where as solid arrows indicate measures that were experimentally assessed in this study.
